These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 3089000)

  • 41. Review of epidemic aminoglycoside resistance worldwide.
    Mayer KH
    Am J Med; 1986 Jun; 80(6B):56-64. PubMed ID: 3089005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.
    Lindemann PC; Risberg K; Wiker HG; Mylvaganam H
    APMIS; 2012 Jun; 120(6):495-502. PubMed ID: 22583362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies on the antimicrobial activities of gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa isolated at Hokkaido University Hospital].
    Sato K; Matsumiya H; Saito A
    Jpn J Antibiot; 1982 May; 35(5):1240-8. PubMed ID: 6813532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive study to investigate the role of various aminoglycoside resistance mechanisms in clinical isolates of Acinetobacter baumannii.
    Sheikhalizadeh V; Hasani A; Ahangarzadeh Rezaee M; Rahmati-Yamchi M; Hasani A; Ghotaslou R; Goli HR
    J Infect Chemother; 2017 Feb; 23(2):74-79. PubMed ID: 27889248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.
    Clark RB; Pakiz CB; Hostetter MK
    Med Microbiol Immunol; 1990; 179(2):77-86. PubMed ID: 2113159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
    Adwan K; Abu-Hasan N; Al-Asmar H
    J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.
    Moody MM; de Jongh CA; Schimpff SC; Tillman GL
    JAMA; 1982 Sep; 248(10):1199-202. PubMed ID: 6809965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.
    Vanhoof R; Godard C; Nulens E; Nyssen HJ; Wildemauwe C; Hubrechts JM; Maes P; Hannecart-Pokorni E
    J Hosp Infect; 1993 Jun; 24(2):129-38. PubMed ID: 8104976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases].
    Díaz PQ; Bello HT; Domínguez MY; Trabal NF; Mella SM; Zemelman RZ; González GR
    Rev Med Chil; 2004 Oct; 132(10):1173-8. PubMed ID: 15631204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage.
    Knothe H; Lebek G; Krcméry V; Seginková Z; Cervenka J; Antal M; Mitsuhashi S
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):506-10. PubMed ID: 6800151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Scribner RK; Marks MI; Weber AH; Tarpay MM; Welch DF
    Antimicrob Agents Chemother; 1982 Jun; 21(6):939-43. PubMed ID: 6810757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
    Heinert G; Wyrobnik J; Scherberich J; Mondorf W; Weber W
    Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.
    Ghotaslou R; Yeganeh Sefidan F; Akhi MT; Asgharzadeh M; Mohammadzadeh Asl Y
    Microb Drug Resist; 2017 Oct; 23(7):826-832. PubMed ID: 28151044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of pediatric infections with amikacin as first-line aminoglycoside.
    Shulman ST; Yogev R
    Am J Med; 1985 Jul; 79(1A):43-50. PubMed ID: 4025367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
    Price KE; DeFuria MD; Pursiano TA
    J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
    Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Washington JA; Snyder RJ; Kohner PC; Wiltse CG; Ilstrup DM; McCall JT
    J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.